Sector
PharmaceuticalsOpen
₹25.04Prev. Close
₹25.55Turnover(Lac.)
₹2.66Day's High
₹25.04Day's Low
₹25.0452 Week's High
₹30.8852 Week's Low
₹6.27Book Value
₹8.41Face Value
₹10Mkt Cap (₹ Cr.)
13.12P/E
0EPS
0Divi. Yield
0Y/e 31 Mar( In .Cr) | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
---|---|---|---|---|
Equity Capital | 5.24 | 5.24 | 5.24 | 5.24 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | -5.89 | -5.95 | -6.18 | -8.03 |
Net Worth | -0.64 | -0.71 | -0.94 | -2.79 |
Minority Interest |
Y/e 31 Mar( In .Cr) | Mar-2020 | Mar-2019 | Mar-2018 | Mar-2017 |
---|---|---|---|---|
Revenue | 0.47 | 0.15 | 0 | 0.25 |
yoy growth (%) | 212.02 | 0 | -100 | -86.57 |
Raw materials | -0.31 | -0.09 | 0 | -0.24 |
As % of sales | 67.2 | 60.93 | 0 | 94.21 |
Employee costs | -0.21 | -0.1 | -0.05 | -0.06 |
Y/e 31 Mar( In .Cr) | Mar-2020 | Mar-2019 | Mar-2018 | Mar-2017 |
---|---|---|---|---|
Profit before tax | -0.26 | -0.24 | -0.24 | -0.49 |
Depreciation | -0.01 | 0 | 0 | 0 |
Tax paid | 0 | 0 | 0 | 0 |
Working capital | 0.01 | -0.14 | 0.01 | -0.16 |
Other operating items |
Y/e 31 Mar | Mar-2020 | Mar-2019 | Mar-2018 | Mar-2017 |
---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | 212.02 | 0 | -100 | -86.57 |
Op profit growth | 6.49 | -1.4 | -60.68 | 346.75 |
EBIT growth | 10.95 | -0.86 | -50.68 | 256.19 |
Net profit growth | 15.28 | -2.01 | -81.87 | 868.92 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd SUNPHARMA | 1,669.3 | 93.52 | 4,00,520.99 | 2,000.46 | 0.96 | 7,107.14 | 101.44 |
Divis Laboratories Ltd DIVISLAB | 6,613.75 | 79.48 | 1,75,574.28 | 667 | 0.45 | 2,536 | 561.08 |
Cipla Ltd CIPLA | 1,512.75 | 25.39 | 1,22,186 | 1,485.4 | 1.06 | 4,254.47 | 397.41 |
Dr Reddys Laboratories Ltd DRREDDY | 1,321.2 | 20.61 | 1,10,263.53 | 1,200.7 | 0.61 | 5,546.3 | 345.76 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 3,225.7 | 57.29 | 1,09,167.44 | 474 | 0.99 | 2,385 | 224.33 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Managing Director
N Krishnaniah
Independent Director
Meena Kumari Pilli
Non Executive Director
Swapneswar Mishra
Company Sec. & Compli. Officer
Sandan Grover
Independent Director
Mr Reddeppa Gundluru
Independent Director
D. Rakesh Reddy
WTD & Additional Director
Sadhanala Venkata Rao
Sy No 115 Brig Sayeed Road,
Hanumanji Colony Old Bowenpall,
Telangana - 500009
Tel: -
Website: http://www.venmaxdrugs.com
Email: [email protected]
214 RaghavaRatna Tow,
Chiragali Lane, Abids,
Hyderabad 500001
Tel: 91-040-23202465/2320
Website: www.cilsecurities.com
Email: [email protected]
Summary
Venmax Drugs & Pharmaceuticals Limited, (VDPL) was initially incorporated as Private Limited Company under the name and style of Yenkay Medico Private Limited, on 28 September, 1998. The Company there...
Read More
Reports by Venmax Drugs & Pharmaceuticals Ltd
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.